Charite University Hospital Berlin

Berlin, Germany


Department of Nuclear Medicine


Winfried Brenner

Prof. Dr. med.

Winfried Brenner

Specialized in: Nuclear Medicine

Curriculum vitae keyboard_arrow_down

University Education

  • 1992 M.D., state examination, Universitätsmedizin Ulm
  • 2002 Habilitation in Nuclear Medicine, Universitätsklinikum Kiel

Professional Experience (selection)

  • 1992-1998 Physician and Research Assistant, Department of Nuclear Medicine, Universitätsklinikum Kiel
  • 1998-2002 Assistant Director, Department of Nuclear Medicine, Universitätsklinikum Kiel
  • 2002-2004 Visiting Assistant Professor, University of Washington, USA
  • 2004-2009 Professor of Nuclear Medicine (C3), Director PET/CT, Department of Nuclear Medicine, Universitätsklinikum Hamburg-Eppendorf
  • 2009 Head of the Department of Nuclear Medicine, Charité
Publications keyboard_arrow_down

https://forschungsdatenbank.charite.de/ForschungDB/ForschungDB/Recherche?7&search=WINFRIED+BRENNER+LG:+DE

The Department of Nuclear Medicine at the Charite University Hospital Berlin, headed by Prof. Dr. med Winfried Brenner, offers the entire spectrum of radioisotope diagnosis and radionuclide therapy. As for the field of diagnostic imaging, the Department of Nuclear Medicine at the Charite University Hospital, headed by Prof. Dr. med Winfried Brenner, is equipped with the most advanced two-chamber systems of single-photon emission computed tomography (SPECT) in all three subunits, including a few hybrid SPECT/CT – systems of innovative construction as well as the advanced PET/CT – (PET: positron emission tomography) systems with the Time-of-Flight function for the highest image quality. 

Moreover, the Department has a few radiochemical modules, including a cyclotron for the creation of radioactive isotopes in order to image by means of SPECT and PET as well as for the creation of radioisotope drugs. Within the framework of nuclear medicine, the Department supervises the unit with 17 beds. This unit provides all standard radioisotope drugs, for example, for thyroid disease as well as a wide range of new treatment options, such as radioimmunotherapy for lymphomas, radio-peptide therapy for neuroendocrine tumors or selective internal radiation therapy (SIRT) for primary liver tumors and liver metastasis.

Along with the general range of conventional nuclear diagnosis and PET/CT, the Department of Nuclear Medicine at the Charite University Hospital, headed by Prof. Dr. med Winfried Brenner, offers complex therapy types, such as:

  • Radioiodine therapy for benign diseases or thyroid cancer
  • Radio-peptide receptor therapy for neuroendocrine cancer
  • Selective internal radiation therapy (SIRT) for multiple liver metastasis
  • Treatment of MIBG (metaiodobenzylguanidine) for neuroblastomas
  • Radiosynovectomy as intra-articular therapy
  •  Cevalin treatment in case of CD20-positive lymphomas
  • Palliative pain therapy in case of bone metastasis 



About hospital

Accommodation in hospital